This Article Full Text Full Text (PDF) All Versions of this Article: 0008-5472.CAN-06-3102v1 66/23/11097    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sloane, B. F. Articles by Sullivan, D. C. Search for Related Content PubMed PubMed Citation Articles by Sloane, B. F. Articles by Sullivan, D. C.

I2 Imaging: Cancer Biology and the Tumor Microenvironment

¹ Department of Pharmacology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan; ² Department of Radiology, University of Arizona, Tucson, Arizona; ³ Division of Cancer Biology and ⁴ Cancer Imaging Program, National Cancer Institute, NIH, Bethesda, Maryland

Requests for reprints: Bonnie F. Sloane, Department of Pharmacology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201. Phone: 313-577-1580; E-mail: bsloane{at}med.wayne.edu.

The use of imaging techniques to understand the role of the tumor microenvironment in cancer progression was the topic of a National Cancer Institute (NCI)–sponsored think tank entitled "I2 Imaging: Cancer Biology and the Tumor Microenvironment," held in Alexandria, Virginia on June 8 to 10, 2006. Participants discussed both recent progress in the use of imaging to dissect cellular and molecular interactions within the tumor microenvironment and the challenges that remain. Recommendations made to the NCI included (a) holding an annual meeting at which biologists, clinicians, and imaging scientists could exchange data, facilitating new collaborations within this multidisciplinary field; (b) funding both research and training specifically designed to foster a cross-disciplinary focus; (c) creating and making available a variety of resources to interested investigators, such as a repository of stromal cells and extracellular matrix molecules; and (d) taking steps to encourage translation of the basic research findings into the clinic. (Cancer Res 2006; 66(23): 11097-9)

This article has been cited by other articles:

				K. A. Krohn and J. G. Rajendran Hypoxia Imaging ASCO Educational Book, January 1, 2008; 2008(1): 538 - 541. [Abstract] [Full Text] [PDF]